Plasma Collection Center Software: Enforcing Donor Eligibility Without Stopping the Floor

Why a plasma center is a regulated manufacturing floor with a queue in it

A donor walks in at 7:40am. The screening station has fourteen minutes before the schedule slips. In that time the center has to confirm identity, check whether this donor is deferred anywhere in the network or on the industry deferral registry, take vital signs, run a protein and hematocrit check, complete the health history questionnaire, confirm the interval since the last donation, and compute the permitted collection volume from the donor's weight band. Then the donor sits down on a device that runs for most of an hour, and the unit produced enters an inventory that will not be released for months.

Two things are true at once and they pull in opposite directions. Every one of those checks is a regulated control on a product that will be manufactured into a therapy for a patient. And the entire economics of the center depend on donor throughput and on donors coming back. Software that enforces the controls but slows the queue destroys the business. Software that keeps the queue moving by making checks easy to bypass destroys the license.

That tension is why plasma center software is a genuinely hard category and why so few products exist. Haemonetics NexLynk and Mak-System are the names you will encounter, and both are real systems built by organisations that understand the domain. The reason networks still consider building is that the parts that differ between operators, the deferral rule set, the compensation and loyalty structure, the center layout and the queueing model, are exactly the parts that decide throughput and donor retention, and they are the parts a packaged product configures rather than expresses.

Problem one: a deferral is a network fact, not a center fact

Deferrals arrive from many directions. A physician substitute defers a donor at screening. A test result comes back reactive and the deferral is applied retroactively, which also affects units already collected. A donor appears on the industry maintained national deferral registry that the sector operates specifically because donors move between centers and between companies.

The failure mode that keeps directors of operations awake is simple. A donor deferred at center A drives to center B, which is twenty minutes away and part of the same network, and presents there. If the deferral check runs against local data, or against a nightly synchronised copy, the donor is accepted. If a deferral is applied retroactively after a test result, the system must find every unit already collected from that donor since the relevant date and quarantine them, and it must do so across the network rather than in one center's records.

A build worth paying for treats the donor as a single network wide record with an authoritative eligibility state evaluated at the moment of presentation, not cached. It handles deferrals as objects with type, reason, start, interval, owner and release conditions, and it applies retroactive scope by query so a reactive result can reach backwards and bind the right units. This is the first thing to test in any evaluation.

Problem two: eligibility is many rules, and they are not all the same kind of rule

Some rules are regulatory and fixed by the applicable federal requirements for source plasma collection, such as the limits on donation frequency within a seven day period and the requirement that permitted collection volume follows the donor's weight band. Some are quality programme rules the industry applies voluntarily, including the qualified donor concept under which plasma from a new donor is only released once that donor has been confirmed by a subsequent donation within a defined window, which is why an inventory hold exists at all. Some are your own company policy, which may be stricter. Some are center specific, because a center may be running under a particular corrective action.

Mixing those into one hard coded eligibility check is how systems become impossible to change. When a rule is updated, nobody can tell whether the change touches a regulatory requirement that needs validation evidence or an internal policy that does not.

The right structure separates them explicitly. Rules carry a source, an owner, an effective date and a version. The evaluation output is not a yes or no but a decision record listing every rule evaluated and its result, stored with the donation. That record is what an inspector reads, what a physician substitute reviews on an override, and what lets you answer, two years later, exactly why this donor was accepted on that day.

Problem three: throughput is a queueing problem the software usually ignores

Center layout is a production line: reception, screening booths, a phlebotomy floor with a fixed number of devices, and a post donation area. Throughput is limited by whichever station is currently the constraint, and that changes through the day. Screening is the constraint at open, devices are the constraint mid morning, and post donation is the constraint when several donations finish together.

Most donor management software treats the visit as a sequence of screens and has no model of the floor at all. So the center manager manages the queue by walking it, and the network has no comparable data on where time actually goes across centers.

A custom build can instrument the visit properly: time at each station, waiting versus service time, and the current constraint. Staff scheduling can then match the actual shape of demand rather than a flat roster, and when one center outperforms another on donations per hour you can see why.

Problem four: the record is regulated, so the software is regulated

This is where custom builds in this sector go wrong when they are approached like ordinary business software. The donor record and the donation record are part of a regulated manufacturing record. Electronic records and electronic signatures carry federal expectations about audit trails, access control and record integrity. The system will be inspected. Changes to it need documented validation. Deleting or editing a record in place is not acceptable.

Practically, that means an append only event model where corrections are new events referencing the original, authentication tied to individual identity with no shared logins at the screening station, an audit trail that captures who saw and changed what, and a release process for software changes that produces evidence rather than a deployment note. A developer who does not raise validation before you do is the wrong developer.

Problem five: compensation is the retention engine and it is also a control

Donors are compensated, and compensation structure drives return rate, which drives collected litres, which is the whole business. Networks run tiered schedules, bonuses for consecutive donations, promotional periods and referral incentives, and they change them frequently because they compete for donors locally.

Off the shelf systems support a compensation model. They rarely support your compensation model changing next month in three of your twenty centers. So operators run promotions on spreadsheets and pay adjustments manually, which is both an operating cost and a control weakness, because payment adjustments outside the system are exactly what fraud looks like.

A build should hold compensation as versioned, effective dated schedules by center and donor segment, calculate at the point of donation, and post to the payment card provider as a controlled transaction with its own reconciliation. Then a promotion is a configuration change made by marketing on Monday rather than a request to information technology, and every payment traces to a donation.

What a custom plasma center build has to include

• A single network wide donor record with eligibility evaluated live at presentation rather than from a cached or nightly copy.
• Deferrals as objects with type, reason, interval, owner and release conditions, including retroactive scope that binds already collected units.
• An eligibility engine that separates regulatory requirements, industry quality programme rules and internal policy, each versioned with an effective date, producing a stored decision record per donation.
• Health screening with vital signs, protein and hematocrit capture, weight based collection volume determination and a supervised override path with recorded reason.
• Integration with collection devices and the testing laboratory so procedure data and results attach to the donation without transcription.
• Unit lifecycle covering collection, inventory hold, qualification, release or quarantine, with full chain of custody to shipment.
• Versioned compensation schedules by center and segment, calculated at donation and posted to the payment provider with reconciliation.
• An append only record model with individual authentication, complete audit trail and a validated change control process for the software itself.

What this costs and how long it takes

A focused first release, meaning the network donor record, deferral enforcement, health screening and the eligibility engine, runs $110,000 to $220,000 and ships in 14 to 20 weeks. That range is higher than an equivalent unregulated build because validation, audit trail and access control are in scope from the start rather than added later. A full platform adding device and laboratory integration, unit release and inventory hold, compensation and loyalty, appointment scheduling and network reporting runs $300,000 to $700,000 phased over 12 to 20 months.

What drives the number up here: the number of centers, mostly through rollout, training and the operational discipline of a staged cutover; device integration, since plasmapheresis equipment on a floor is a real integration rather than an interface exercise; laboratory interfaces, because results drive retroactive deferral and unit disposition and must be right; the payment card provider integration; and the depth of validation your own quality system requires.

What keeps the number down: run the first release in two centers and migrate only the historical data that eligibility evaluation actually needs.

When you should not build this

Do not build below roughly five centers. A validated commercial system from Haemonetics or Mak-System will cost less than owning the validation burden, and at that scale your differentiation is donor experience in the building rather than the software behind it. Do not build if you have no quality assurance function capable of owning computer system validation, because the software is only half the obligation.

Build when two or more of these are true. You operate enough centers that a deferral has to be a network fact and your current answer involves synchronisation. You compete on compensation and loyalty and cannot change a schedule without a vendor request. You are opening centers faster than your vendor can configure them. Your throughput varies between centers and nobody can say why with data. Your device and laboratory data reaches the donation record through transcription. At that point the operating logic of the network is the asset, and it should not sit inside a product configured for a competitor as well.

How to choose a developer for plasma collection software

Ask them what computer system validation means for this build, before you raise it. If they treat it as documentation to be produced at the end, they will produce a system that fails inspection and a project that reopens. The correct answer runs validation alongside development and produces evidence as a by product of how the team works.

Ask them to describe how a reactive test result propagates. A team that has done regulated collection work will immediately talk about retroactive deferral, finding already collected units, quarantine and notification. A team that describes updating a donor status field has built a booking system.

Ask how they handle overrides. Every real center needs a physician substitute to be able to override an eligibility decision in defined circumstances. A system with no override path will be worked around within a week, and a system with an unlogged override is worse than none.

Ask who owns the code and get it in writing before kickoff. You should own the repository, the infrastructure accounts, the validation documentation and the unrestricted right to hire another firm. The validation package matters as much as the source here, because without it your next developer starts the evidence trail again. At Digital Heroes the client owns the code from the first commit.